Avastin Approved in EU and Switzerland
Avastin (bevacizumab) is added to chemotherapy regimens to help treat colorectal cancer that has spread. It is approved for use in the United States, Israel, and now the European Union and Switzerland. Reported February 3, 2005.

EU Approves Use of Oxaliplatin for Stage 3 Colon Cancer
The successful completion of the Mutual Recognition Procedure in Europe resulted in the European Union's approval of oxaliplatin in the treatment of stage 3 colon cancer. Reported October 25, 2004.

Avastin Warning
FDA and Genentech recently issued a drug warning to healthcare providers regarding Avastin. They have found new risks associated with the drug. Reported August 17, 2004.

Adding Avastin May Add Years to Your Life
A recent study found that colon cancer patients who added Avastin (bevacizumab) to their chemotherapy regimen fared better than those using the standard regimen alone. Reported June 20, 2004.